Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 3:23 PM UTC
| NCT Number | NCT06087653 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Starton Therapeutics, Inc |
| Last Updated on CT.gov | June 19, 2025 (Jun 19, 2025) |
As of March 2, 2026: Clinical trial NCT06087653 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Starton Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06087653 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06087653 was last updated Jun 19, 2025 (June 19, 2025). HelloStudys verifies this status automatically.